Earlier this week, the Texas Legislature adjourned after its 140-day legislative session. This year's session brought successes and setbacks. Prohibitionists went to great lengths to keep the status quo and some of their reefer madness unfortunately worked.
What Passed:
Industrial Hemp Legalization – HB 1325 legalizes industrial hemp in Texas and establishes a regulatory structure so that Texans may soon start growing hemp.
Limited Low-THC Medical Cannabis Expansion – HB 3703 removes the two-physician…
The National Academies of Sciences released a report on the health impacts of marijuana Thursday, confirming the existence of medical benefits and dispelling some long-held myths about the substance.
The review of more than 10,000 scientific abstracts found, “There is conclusive or substantial evidence that cannabis or cannabinoids are effective” for the treatment of chronic pain in adults, chemotherapy-induced nausea and vomiting, and multiple sclerosis spasticity.
The report also dispels several…
Major news: It was announced today that Sativex, a cannabinoid-based liquid medicine sprayed under the tongue, has been approved for use in Great Britain to help treat the muscle spasticity suffered by multiple sclerosis patients. Sativex is a natural marijuana extract that is produced by British-based GW Pharmaceuticals. It has been approved for use in Canada to treat neuropathic pain since 2005.
“Once again, the scientific community has confirmed that marijuana is medicine and it can provide safe…
A report published yesterday in the online journal BMC Neurology says that marijuana might help multiple sclerosis patients find relief from the spasticity and muscle spasms caused by the debilitating autoimmune disease.
“We found evidence that cannabis plant extracts may provide therapeutic benefit for MS spasticity symptoms,” said lead researcher Dr. Shaheen Lakhan, executive director of the Global Neuroscience Initiative Foundation. “The therapeutic potential of cannabinoids in MS appears to be…
